- Home
- JSPR vs XYF Comparison
JSPR vs XYF Comparison
Compare JSPR & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- XYF
- Stock Information
- Founded
- JSPR 2018
- XYF 2014
- Country
- JSPR United States
- XYF China
- Employees
- JSPR N/A
- XYF N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- XYF Finance: Consumer Services
- Sector
- JSPR Health Care
- XYF Finance
- Exchange
- JSPR Nasdaq
- XYF Nasdaq
- Market Cap
- JSPR 323.0M
- XYF 290.2M
- IPO Year
- JSPR N/A
- XYF 2018
- Fundamental
- Price
- JSPR $22.48
- XYF $7.20
- Analyst Decision
- JSPR Strong Buy
- XYF
- Analyst Count
- JSPR 11
- XYF 0
- Target Price
- JSPR $73.38
- XYF N/A
- AVG Volume (30 Days)
- JSPR 211.1K
- XYF 32.4K
- Earning Date
- JSPR 11-07-2024
- XYF 11-26-2024
- Dividend Yield
- JSPR N/A
- XYF 4.66%
- EPS Growth
- JSPR N/A
- XYF 2.79
- EPS
- JSPR N/A
- XYF 3.88
- Revenue
- JSPR N/A
- XYF $763,521,851.00
- Revenue This Year
- JSPR N/A
- XYF N/A
- Revenue Next Year
- JSPR N/A
- XYF N/A
- P/E Ratio
- JSPR N/A
- XYF $1.88
- Revenue Growth
- JSPR N/A
- XYF 16.99
- 52 Week Low
- JSPR $4.00
- XYF $3.48
- 52 Week High
- JSPR $31.01
- XYF $8.59
- Technical
- Relative Strength Index (RSI)
- JSPR 52.21
- XYF 60.15
- Support Level
- JSPR $20.73
- XYF $6.78
- Resistance Level
- JSPR $26.05
- XYF $7.79
- Average True Range (ATR)
- JSPR 1.60
- XYF 0.33
- MACD
- JSPR -0.10
- XYF 0.07
- Stochastic Oscillator
- JSPR 48.48
- XYF 65.50
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.